Zacks Research Issues Positive Estimate for Avantor Earnings

Avantor, Inc. (NYSE:AVTR) – Stock analysts at Zacks Research boosted their Q2 2027 earnings estimates for Avantor in a research note issued to investors on Wednesday, May 20th. Zacks Research analyst Team now expects that the company will earn $0.19 per share for the quarter, up from their prior estimate of $0.16. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Avantor’s current full-year earnings is $0.79 per share. Zacks Research also issued estimates for Avantor’s Q4 2027 earnings at $0.23 EPS and FY2027 earnings at $0.84 EPS.

AVTR has been the topic of a number of other reports. Evercore set a $10.00 price target on shares of Avantor in a report on Wednesday, February 11th. Citigroup lowered their price target on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Jefferies Financial Group reaffirmed an “underperform” rating and issued a $8.00 target price on shares of Avantor in a research note on Thursday, February 12th. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Barclays lowered their target price on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.82.

Avantor Trading Down 0.3%

Shares of Avantor stock opened at $7.86 on Friday. Avantor has a 12-month low of $7.26 and a 12-month high of $15.93. The company has a market cap of $5.36 billion, a price-to-earnings ratio of -9.70, a PEG ratio of 4.57 and a beta of 0.94. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. The company’s 50-day moving average price is $7.95 and its 200-day moving average price is $9.88.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the prior year, the firm posted $0.23 earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis.

Insider Buying and Selling at Avantor

In other Avantor news, Director Sanjeev K. Mehra purchased 125,000 shares of Avantor stock in a transaction on Tuesday, March 10th. The shares were acquired at an average cost of $8.01 per share, for a total transaction of $1,001,250.00. Following the completion of the transaction, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. The trade was a 35.71% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Simon Dingemans purchased 25,000 shares of Avantor stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 160,000 shares of company stock worth $1,287,950 over the last ninety days. Insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Dodge & Cox grew its holdings in shares of Avantor by 0.3% in the third quarter. Dodge & Cox now owns 117,746,888 shares of the company’s stock worth $1,469,481,000 after purchasing an additional 313,404 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Avantor by 1.8% in the third quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock worth $823,542,000 after purchasing an additional 1,135,279 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of Avantor by 10.8% in the third quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 34,548,129 shares of the company’s stock worth $431,161,000 after purchasing an additional 3,356,861 shares during the last quarter. Wellington Management Group LLP bought a new position in shares of Avantor in the fourth quarter worth approximately $268,584,000. Finally, Greenhaven Associates Inc. grew its holdings in shares of Avantor by 12.0% in the fourth quarter. Greenhaven Associates Inc. now owns 20,500,653 shares of the company’s stock worth $234,937,000 after purchasing an additional 2,189,083 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Key Stories Impacting Avantor

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Zacks Research raised its Q2 2027 EPS estimate to $0.19 from $0.16, implying improved earnings expectations further out.
• Positive Sentiment: Analysts also lifted Q4 2027 EPS estimates to $0.23 from $0.22, and FY2027 estimates to $0.84 from $0.82, which may support sentiment around Avantor’s longer-term earnings trajectory.
• Positive Sentiment: FY2028 EPS estimates were increased to $0.91 from $0.84, another sign that some analysts see better profitability ahead for Avantor.
• Neutral Sentiment: Zacks Research maintained a Hold rating on Avantor, suggesting the firm is not yet calling for a major re-rating despite the higher estimates.
• Negative Sentiment: Near-term estimates were cut for FY2026, Q2 2026, Q3 2026, and Q1 2027, which can weigh on the shares because investors often focus on the next few quarters first.
• Negative Sentiment: A post-Q1 earnings article questioning whether the stock is a buy, sell, or hold may also reflect continued skepticism about the near-term setup for AVTR. Avantor (AVTR): Buy, sell, or hold post Q1 earnings?

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.